top of page
The Professional Network for Healthcare Experts
Mankind Pharma agrees €48 million acquisition of 70% stake in Armed Cell Therapeutics to enter CAR-T oncology
Mankind Pharma has agreed to acquire a 70% stake in Belgium's Armed Cell Therapeutics for €48 million, marking its entry into next-generation CAR-T oncology therapies.
nuaxia
3 days ago2 min read
Mankind Pharma licenses insulin degludec and insulin degludec–aspart combination for India
The exclusive agreement expands Mankind Pharma's injectable diabetes portfolio with two long-acting insulin analogues while strengthening its strategy of in-licensing innovative therapies for the Indian market.
nuaxia
Aug 212 min read
bottom of page